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Brain microvasculature forms a specialized structure, the blood-brain barrier (BBB),
to maintain homeostasis and integrity of the central nervous system (CNS). The
BBB dysfunction is emerging as a critical contributor to multiple neurological
disorders, including stroke, traumatic brain injury, autoimmune multiple sclerosis,
and neurodegenerative diseases. The brain microvasculature exhibits highly cellular
and regional heterogeneity to accommodate dynamic changes of microenvironment
during homeostasis and diseases. Thus, investigating the underlying mechanisms that
contribute to molecular or cellular changes of the BBB is a significant challenge. Here,
we describe an optimized protocol to purify microvessels from the mouse cerebral cortex
using mechanical homogenization and density-gradient centrifugation, while maintaining
the structural integrity and functional activity of the BBB. We show that the isolated
microvessel fragments consist of BBB cell populations, including endothelial cells,
astrocyte end-feet, pericytes, as well as tight junction proteins that seal endothelial
cells. Furthermore, we describe the procedures to generate single-cell suspensions from
isolated microvessel fragments. We demonstrate that cells in the single-cell suspensions
are highly viable and suitable for single-cell RNA-sequencing analysis. This protocol does
not require transgenic mice and cell sorting equipment to isolate fluorescence-labeled
endothelial cells. The optimized procedures can be applied to different disease models
to generate viable cells for single-cell analysis to uncover transcriptional or epigenetic
landscapes of BBB component cells.
Keywords: blood-brain barrier, endothelial cells, brain capillaries, single-cell isolation, microvasculature damage
INTRODUCTION
The brain vasculature is a complex system composed of endothelial cells, pericytes, astrocytes,
smooth muscle cells, and extracellular matrix components, forming the unique blood-brain barrier
(BBB), which lies at the interface between circulating blood and the neural tissue (Abbott and
Friedman, 2012; Obermeier et al., 2013). The BBB tightly regulates the transport of ions and
nutrients necessary for neuronal health and function. It also prevents harmful substances or cells
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from entering into the central nervous system (CNS). Previous
literature suggests that the BBB disruption can lead to neuronal
injury mediated through peripheral immune cells or harmful
agents that enter into the CNS inmultiple neurological disorders,
such as Alzheimer’s disease (AD; Sweeney et al., 2018; Nation
et al., 2019), ischemic stroke (Kassner and Merali, 2015),
multiple sclerosis (Ortiz et al., 2014), and traumatic brain injury
(Alluri et al., 2015). Despite the importance of BBB highlighted
in many neurological disorders, the molecular and cellular
mechanisms that lead to BBB dysfunction or disruption in
these disease conditions remain largely unknown. Therefore, it
is vital to develop a method to isolate brain microvasculature
with preserved structural integrity to identify subtle aberrations
of the BBB in disease animal models. Here, we describe an
optimized protocol that would allow isolating brain microvessels
that closely resemble in vivo structures suitable for downstream
applications of molecular and single-cell analyses to characterize
molecular signatures of BBB component cells.
MATERIALS AND EQUIPMENTS
Animals
C57BL/6 and db/db mice were purchased from the Jackson
Laboratory and bred at the animal facility of Indiana University
School of Medicine. Mice were housed and maintained at 25◦C
under a 12 h light/ 12 h dark cycle with ad libitum access to food
and water. Adult female mice aged 12–16 weeks or 9 months
were used for the present study. All animal procedures in this
study were conducted following the National Institutes of Health
(NIH) Guide for the Care and Use of Laboratory Animals and
approved by Purdue Animal Care and Use Committee.
Reagents
(1) Sigma–Aldrich Potassium Chloride (SKU: P9541-500G)
(2) Baker Analyzedr Potassium PhosphateMonobasic, Crystal
(CAS: 7778-77-0)
(3) Fisher Sodium Chloride (CAS: 7647-14-5)
(4) Fisher Sodium Phosphate Dibasic Anhydrous (CAS: 7558-
79-4)
(5) Fisher Calcium Chloride Dihydrate (CAS: 10035-04-8)
(6) Fisher Magnesium Chloride (CAS: 7791-18-6)
(7) Sigma Aldrich D-(+)-glucose (SKU: G8270-100G)
(8) Sigma–Aldrich Sodium Pyruvate (Product number: P2256)
(9) Thermo Fisher Scientific GE Healthcare Ficoll PM400
(Catalog number: 45-001-745)
(10) Elko Filtering Co 30 micron nylon mesh (Catalog number:
NC0478162)
(11) Sefar, 03-100/32, Nylon Mesh Filtering Screen
100 Micron—Open Area %: 32— Width: 38 in, Natural
Color (1 Yard; Part number: 3A03-0100-098-00)
(12) Alkali Scientific Inc. 100 micron strainer (Catalog number:
TS100)
(13) Thermo Fisher Scientific SartoriusTM glass beads
(0.4 mm–0.6 mm; Catalog number: BBI-8541701)
(14) Sigma–Aldrich Bovine Serum Albumin (BSA; Catalog
number: A2153)
(15) Sigma–Aldrich Collagenase (Catalog number: C5138)
(16) Sigma–Aldrich DNase I (Catalog number: DN25)
(17) BioLegend APC/Cy7 anti-mouse CD45 (clone: 30-F11)
(18) BioLegend Alexa Fluor 488 anti-mouse CD31 (clone:
MEC13.3)
(19) BioLegend 7-AAD Viability Staining
(20) Miltenyi Biotec APC anti-mouse ACSA2 (clone: IH3-18A3)
(21) Miltenyi Biotec FcR blocking reagent—mouse
(22) BioLegend anti-mouse CD140b (clone: APB5)
(23) BD Bioscience anti-mouse CD31 (clone: MEC13.3)
(24) Sigma–Aldrich Rabbit anti-Aqp4 (Catalog number:
HPA014784)
(25) Thermo Fisher Scientific Rabbit anti-ZO-1 (Catalog
number: 61-7300)
(26) Proteintech Rabbit anti-Occludin (Catalog number: 13409-
1-AP)
(27) BD Bioscience Mouse anti-actin (Catalog number: 612656)
(28) Sigma–Aldrich Phosphate Buffered Saline with 10% Bovine
Albumin (BSA; Catalog number: SRE0036)
(29) Anaspec HiLyteTM Fluor 488 labeled human amyloid
beta-peptide 1–42 (Catalog number: AS-60479-01)
(30) Sigma–Aldrich PSC833 (Catalog number: SML0572)
Isolation Equipment
(1) Milwaukee 12 in (13 mm) drill (Catalog number: 0299-20)
(2) Wheaton Dounce homogenizer—7 ml (Catalog number:
3432T40)
(3) Staco Energy Products Variable Autotransformer (Model:
3PN1010B)
(4) Beckman Coulter Avanti J-E centrifuge
(5) Beckman JA-20 rotor (20,000 rpm)
(6) Fotodyne Stovall The Belly Dancer Hybridization Water
Bath (SKU: 7121211)
(7) Eppendorf 5810 R Centrifuge
Analysis Equipment and Software
(1) BD FACSVerseTM
(2) Olympus FV10i confocal microscope
(3) Olympus DP72 light microscope
(4) Applied Biosystems StepOne Plus real-time PCR system
(5) NIH ImageJ software
(6) Prism 8
STEP-BY-STEP PROCEDURES
Day Before Experiment
(1) Prepare modified phosphate-buffered saline (PBS,
2.7 mmol/L KCl, 1.5 mmol/L KH2PO4, 136.8 mmol/L NaCl,
4.3 mmol/L Na2HPO4, 0.7 mmol/L CaCl2, 0.5 mmol/L
MgCl2, pH 7.4). The volume of 500 ml modified PBS would
be used for 3–5 mice.
(2) Prepare 8 ml of 40% Ficoll solution in modified PBS per
group.
(3) Store both the modified PBS and the 40% Ficoll in 4◦C.
Day of Experiment
(1) AddD-glucose (5mmol/L) and sodium pyruvate (1mmol/L)
to the modified PBS.
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(2) Prepare 1% BSA in modified PBS.
(3) Place all buffers on ice and pre-cool all tools and centrifuges.
Brain Microvessel Fragments for
Molecular Assays
(1) Anesthetize mice using isoflurane. When the animals are
asleep, sterilize the animals with 70% ethanol, and decapitate
the animals. Extract brains as described in Figure 2 and
transfer brains to a Petri dish containing ice-cold modified
PBS. Carefully remove the thin slices of subdural meninges
(SDM) on the dorsal surface of the brain. Use the dissecting
microscope to validate the removal of SDM quickly. Keep the
brain on ice.
(2) Using the brain matrix, remove olfactory bulbs and
cerebellum. Cut the brain in half horizontally. Using Needle
blade, separate the cortex from the corpus callosum. Place
cortices in a glass tube containing 7 ml ice-cold modified
PBS.
(3) In a 4◦C cold room, homogenize cortices for 35 strokes using
an electrical drill (Milwaukee drill connected to the Staco
Energy Products Autotransformer)
(a) Speed for the first 20 strokes: 18
(b) Speed for the last 15 strokes: 20
(c) Transfer homogenates to Dounce homogenizer and
homogenize manually for additional 10 strokes.
(4) Mix brain homogenate with an equal volume of 40% Ficoll
solution to a final concentration of 20% Ficoll PM 400. Shake
tubes before centrifuge.
(5) The homogenate will be spun at 5,800× g, 4◦C for 20 min.
(6) Discard supernatant and vacuum the myelin layer at the top.
(7) The pellet containing enrichedmicrovessels can then be used
for molecular assays such as RNA extraction or Western
blot analysis. Add the appropriate volume of Trizol or RIPA
buffer to the pellet and re-suspend it gently for downstream
analyses.
Purification of Brain Capillaries for
Imaging/Functional Assays
(1) In a 4◦C cold room, take the pellet containing enriched
microvessels from the previous step and re-suspend it into
1 ml of 1% BSA/modified PBS.
(2) Filter the solution with 300 µm nylon mesh and wash the
mesh with 10 ml of 1% BSA/modified PBS and save the
flow-through.
(3) Filter the flow through with 30 µm strainer very slowly by
using a 7ml transfer pipet. The speed of the droplet is 1 drop
every 2 s. Capillaries will be captured on top of the strainer.
(4) Carefully invert the 30 µm strainer and wash with 10 ml of
1% BSA/modified PBS.
(5) Prepare an enrichment column in a 4◦C room and add a
volume of 15 ml glass beads to a 30 ml syringe supported by
a 30 µm nylon mesh.
(6) Rinse the column with 10 ml of 1% BSA/modified PBS
before adding the capillary solution.
(7) Transfer the capillary solution into the syringe by using a
7 ml transfer pipet.
(8) Gently agitate the beads, but do not touch the bottom 5 ml
of beads.
(9) Adjust the flow rate so that the speed of the droplet is 1 drop
per every 2 s.
(10) Rinse with 10 ml of 1% BSA/modified PBS one time, gently
agitating the beads after adding the buffer.
(11) Rinse with 10 ml of BSA-free PBS twice, gently agitating the
beads after adding the buffer.
(12) Brain capillaries will be bound by the glass beads.
Collect capillaries by pouring the beads into a sterile
glass beaker.
(13) Add 50 ml of BSA-free modified PBS and gently agitate by
aspirating the beads with a 25 ml serological pipet.
(14) Filter the solution into a clean 50 ml Falcon tube supported
by a 100 µm strainer to capture the glass beads.
(15) Repeat the wash step of glass beads one time with an
additional 50 ml of BSA-free modified PBS and filter the
solution into another clean 50 ml Falcon tube.
(16) Centrifuge 50 ml Falcon tubes at 1,100 rpm, 4◦C for 5 min.
At the end of the centrifugation, remove supernatant and
combine the pellets into one tube.
(17) Wash the pellet with 50 ml BSA-free modified PBS for an
additional two times.
(18) Re-suspend the pellet in 250 µl 1% BSA/modified
PBS. The enriched capillaries can be examined by
light microscopy.
(19) For imaging, load 20 µl of re-suspended capillaries on a
glass coverslip, spreading in a Z-shaped manner gently.
(20) Let the capillaries attach to the glass coverslip at room
temperature for 30 min.
(21) Wash with 1 ml of 1% BSA/modified PBS. After wash,
the capillaries can be fixed with 2% paraformaldehyde and
subjected to immunostaining analyses.
Generation of Single-Cell Suspensions of
Brain Microvessels
(1) After the glass bead purification step, the capillary pellet can
be used to generate single-cell suspensions. Re-suspend the
enriched capillary pellet in 2 ml of 1× HBSS−/− buffer and
transfer to a new 50 ml Falcon tube.
(2) Add 0.5 mg/ml collagenase, and incubate the solution in a
water bath set to 37◦C with gentle shaking for 15 min. Swirl
the tube gently every 5 min.
(3) At the end of the incubation period, add 2µg/ml DNase, and
gently pipet up and down with a 1 ml wide-bore tip until
aggregate is dissociated.
(4) Incubate the mixture in the hybridization water bath at 37◦C
for 5 min.
(5) At the end of the incubation period, immediately add 13 ml
pre-warmed RPMI-164 media with 10% fetal bovine serum
to quench the enzyme activity.
(6) Pass a total of 15 ml of the mixture through a 70 µm strainer
and transfer to a new 50 ml Falcon tube. Centrifuge mixture
at 1,100 rpm, 4◦C for 5 min.
(7) Remove the supernatant carefully using a pipette and
re-suspend the cell pellet with ice-cold buffer. Pass cell
suspensions through a 40 µm FLOWMI strainer.
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FIGURE 1 | Overview of brain microvessel purification protocol. (A) Representative images of microvessels in the mouse cerebral cortex labeled by
immunofluorescence staining. Scale bar, 20 µm. (B) Flowchart of the isolation procedures. This diagram depicts the major steps to isolate microvessels from freshly
harvested mouse brain. Scale bar, 10 µm. Representative single-cell t-SNE plot shows different colored clusters to identify different cell types.
(8) The viability and cell yield can be examined. At this point,
the cells are ready for downstream applications, such as
single-cell analyses.
RESULTS
To isolate microvessels from the mouse cerebral cortex, as shown
in Figure 1A, we adapted the protocol initially described by
Miller, Bauer, and Hartz groups (Miller et al., 2000; Hartz et al.,
2004, 2018b; Wang et al., 2010, 2014). The isolated microvessel
fragments using mechanical homogenization described by Miller
et al. (2000) retain P-glycoprotein, an ATP-dependent efflux
transporter of the BBB and maintain the functional transport
activity (Hartz et al., 2010, 2018b; Wang et al., 2010, 2014).
We modified the Ficoll density-gradient and homogenization
strokes to obtain optimal sizes of microvessel fragments
from a pool of dissected cortices. The isolation protocol is
overviewed in Figure 1B. The procedures described in Figure 2
yielded intact microvessel fragments as examined under a light
microscope, although there was some brain parenchymal debris
observed (Figures 3A,B). We validated the purity of isolated
microvessels by examining the unique mRNAs expressed in
different cell types. The isolated microvessels showed a 30-fold
enrichment of endothelial cell-specific genes, Pecam1, Cldn5,
and Cdh5, compared to other cell types, such as astrocytes,
neurons, and microglia (Figure 3C). When compared to protein
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FIGURE 2 | Brain microvessel enrichment. (A–C) Tissue harvest and dissection. After head decapitation, peeling the skin to reveal the skull. Extracting the brain
with a spatula. After transferring the whole brain into a Petri dish containing modified phosphate buffered saline (PBS) on ice, dissecting the brain regions on ice.
Dissecting the cerebral cortex was shown. Highlighted area showed the cortex which is cut out using a needle blade. (D–G). Homogenization and Ficoll gradient
enrichment. (D) Multi-speed drill homogenizes collected cortices. (E) Before and after homogenization. (F) An equal amount of 40% Ficoll is added to the
homogenates and transferred to a centrifuge tube. (G) Post-centrifugation shows the myelin layer at the top and the pellet at the bottom, which contains the
brain microvessels.
homogenates of the cerebral cortex, the isolated microvessels
showed enrichment of tight junction protein, Zonula Occludens
(ZO-1) and Occludin, indicating the intact barrier structure of
microvessel fragments (Figure 3D). At this point, the isolated
microvessel fragments can be used for molecular or biochemical
assays to examine changes of tight junction proteins in a
disease model. We examined a well-characterized model of
human obesity and type 2 diabetes, which carries the mutated
leptin receptor (db) alleles (Bahary et al., 1990). The db/db
mouse has been reported exhibiting comorbid phenotypes of
obesity, diabetes, and cognitive deficits (Erion et al., 2014;
Stranahan et al., 2016; Cope et al., 2018). The cerebral vascular
abnormalities and BBB damage were suggested contributing
to the impairment of cognition observed (Niedowicz et al.,
2014; Stranahan et al., 2016). We used this model as our
validation studies for this isolation protocol. We isolated brain
microvessels from db/db mice as procedures described above
and examined the tight junction protein, Occludin (Figure 3E).
The levels of Occludin in the microvessel fragments of db/db
mice were significantly reduced compared to the controls.
These results demonstrated the applications of this protocol
to examine the vascular pathology in a dementia mouse
model.
To exclude unwanted cellular debris, further purification
of the enriched microvessel fragments was accomplished via
the filtration through the glass beads column as shown in
Figures 4A–E. We examined the diameters of the microvessel
fragments using a bright-field light microscope. The majority
of the microvessel fragments captured were less than 10 µm in
diameter (Figures 4F,G). We observed that 75.7% of fragments
were less than 5 µm, and 21.6% of fragments were between 5
and 10 µm (Figure 4H). The results suggested that most of the
purifiedmicrovessel fragments are brain parenchymal capillaries.
This filtration facilitated obtaining stretched and untangled
capillaries that are suitable for imaging analyses (Figure 5A).
We performed immunostaining to characterize the morphology
of purified capillaries. Using the immunostaining of endothelial
cell marker, CD31, we were able to visualize homogeneously
labeled endothelial cells within the intact structure of capillaries
(Figure 5B). Also, the tight junction protein, ZO-1, was
Frontiers in Cellular Neuroscience | www.frontiersin.org 5 April 2020 | Volume 14 | Article 84
Paraiso et al. Isolation of Cerebral Microvessels
FIGURE 3 | Purity of enriched brain microvessels. The enriched
microvessels were examined by light microscope, bright-field directly after
isolation and resuspension. (A) 100× magnification. Arrows indicate different
sizes of microvessel fragments isolated. Scale bar, 50 µm. (B) 400×
magnification. Top insert depicts a single stretched out capillary. The bottom
insert depicts a capillary network attached to smooth muscle cells. Scale bar,
20 µm. (C) Endothelial cell markers (Cdh5, Cldn5, and Pecam1), astrocyte
markers (Aqp4, Slc1a2 m, and S100b), neuron markers (Bdnf and Grin2a),
and microglia markers (Cx3cr1 and Tmem119) were compared between the
enriched brain microvessels and the cortex homogenates using qPCR
quantification. Data are mean ± SEM, n = 2 mice per experiment from two
independent experiments. (D) Representative Western blot shows that tight
junction proteins, ZO-1 and Occludin, were enriched in isolated microvessel
fragments compared to the cortex homogenates. The cytoskeletal β-actin
was used as a control. Ten microgram of total protein preparation was
examined. Data presented are from four independent experiments. (E)
Representative Western blot of enriched brain microvessels isolated from
wild-type C57BL/6 female mice (three samples) and db/db female mice (two
samples) at age of 9 months. The tight junction protein, Occludin, was
diminished in the db/db group. n = 2 mice per experiment from two
independent experiments.
co-labeled with CD31+ endothelial cells with no apparent
discontinuity, suggesting that the structure of endothelial tight
junctions were preserved in our capillary preparation. The
surface of brain capillaries is covered by pericytes and astrocyte
end-feet that seals the BBB entirely resulting in the unique
characteristics of the cerebrovascular system (Daneman et al.,
2010). We performed immunostaining of pericytes and astrocyte
end-feet using makers, PDGFRβ and Aquaporin-4 (App4)
respectively, to examine the sheathing of isolated capillaries.
The PDGFRβ+ pericytes were shown adhered to the surface
of isolated capillaries (Figure 5C). The water channel Aqp4 is
concentrated at the astrocyte end-feet membrane, serving as an
influx route of water to maintain homeostasis (Papadopoulos
and Verkman, 2013; Camassa et al., 2015). We found that
the Aqp4+ end-feet membrane outlined the wall of isolated
capillaries (Figure 5D). Together, these results suggest that our
optimized protocol using mechanical homogenization, but not
enzymatic digestion, preserves the structure of the BBB that
closely mimic in vivo situations.
The purified capillaries using this protocol can be applied for
functional transport assays to test small-molecule drugs (Wang
et al., 2010, 2014). AD is an age-associated neurodegenerative
disorder characterized by the buildup of amyloid-β (Aβ) plaques.
The accumulation of Aβ as the result of unbalanced Aβ
generation subsequent clearance is reported to contribute to the
pathogenesis of AD (Bell et al., 2007; Mawuenyega et al., 2010;
Zlokovic, 2011). We used the transport of human Aβ42 peptide
to validate the function of the purified microvessel fragments
(Figure 6A). We first used freshly isolated capillaries to examine
the transport of Aβ42 (Hartz et al., 2010). We incubated HiLyte-
Fluor 488 labeled Aβ42 peptide (Aβ42–488) or non-labeled Aβ42
peptide with purified capillaries in modified PBS at room
temperature for 1.5 h.We observed the accumulated fluorescence
of Aβ42–488 in the luminal space of capillaries, compared to
non-labeled Aβ42 peptide. The P-glycoprotein inhibitor, PSC833,
to suppress the transport of Aβ42–488 was shown. We tested the
ability of purified capillaries to transport Aβ42–488 at 4h after
purification (Figure 6B). The purified capillaries were incubated
with modified PBS at room temperature for 4 h and then
subjected to the transport assay for 1.5 h as described above. The
reduction of Aβ42–488 fluorescence in the luminal space suggested
that the purified capillaries have reduced function and viability
at 5.5 h after purification, as suggested in previous studies (Bauer
et al., 2008; Hartz et al., 2010, 2018b). We also found that the
CD31 immunostaining signal in purified capillaries is reduced at
4 h and almost diminished at 7 h after purification (Figure 6C).
Together, these results suggested that the purified capillaries
retain the transport function of BBB as in vivo, and the viability
of purified capillaries can be preserved at modified PBS for
up to 5 h.
Transcriptional profiling of the brain vascular endothelial
cells provides new insights into the molecular mechanisms of
vascular function in health and diseases at a whole-genome
level (Guo et al., 2012; Zhang et al., 2014; Sabbagh et al.,
2018). The fluorescence-activated cell sorting (FACS) technique
enables to purify pre-defined cell populations based on the
expression of surface markers or fluorescent reporters (Crouch
and Doetsch, 2018; Jung et al., 2018; Munji et al., 2019). The
selection of appropriate markers is often challenging, as some
commonmarkers being shared among BBB component cells and
other types of brain parenchymal cells, such as oligodendrocyte
progenitor cells. The enzymatic tissue dissociation before FACS
purification is a critical step, as some epitopes required for
immunostaining are degraded in a time-dependent manner
during tissue dissociation (Crouch and Doetsch, 2018).
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FIGURE 4 | Purification of brain capillaries and characterization of capillary size. (A) Passing pellet resuspensions through a 300 µm nylon mesh. (B) Example of
glass beads used. (C) Collection syringe with adjustable flow rate has 15 ml glass beads supported by a 30 µm nylon mesh. (D) Gentle agitation using a glass stirrer
is necessary for microvessels to adhere to glass beads. (E) Filtering solution with a 100 µm filter to remove excess glass beads. (F) Representative bright-field
images of different sizes of capillaries. The diameters of the capillaries were measured. A total of 70–120 capillaries was examined per experiment. Three
independent experiments were performed. Arrow points to the representative capillary with a size between 10 and 20 µm. (G) The size of the capillaries was
examined from each experimental preparation. Data are mean ± SEM n = 5 mice per experiment from three independent experiments. (H) Percentages of capillaries
based on size. Data are mean ± SEM n = 5 mice per experiment from three independent experiments.
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FIGURE 5 | Morphological characterization of purified microvessels. Confocal images of immunostaining for different markers of blood-brain barrier (BBB) cell
components. (A) Phase-contrast (Ph) image of microvessels. The cell nuclei shown by arrowheads are depicted as blue using Hoechst 33342 staining (1 µg/ml).
(B–D) Isolated microvessels retain most of the in situ structure. (B) Endothelial markers, CD31 (red) and tight junction proteins, ZO-1 (green) were detected. (C)
Pericyte markers, PDGFRβ (red) were detected adhering to the surface of an isolated capillary, as shown by arrows. (D) Astrocyte end-feet membranes, pointed by
arrowheads, remain attached to the microvessel fragment. Scale bar, 10 µm. The data presented are from three independent experiments.
The development of single-cell technologies opens the
opportunity to map cellular heterogeneity within BBB
component cells and to unravel the molecular signatures of
previously unrecognized cell populations or functional states in
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FIGURE 6 | Functional transport characterization of purified microvessels. (A,B) Confocal images of Aβ42 transport in purified capillaries. (A) Freshly prepared
capillaries were incubated with 5 µM HiLyte Fluor-488 Aβ42 (Aβ42–488) peptide or non-labeled Aβ42 peptide (as control) in modified PBS at room temperature for
1.5 h. After incubation, capillaries were washed and processed for imaging analysis. Capillary luminal fluorescence (green) of Aβ42–488 was examined using a confocal
microscope. Cell nuclei are shown as blue using Hoechst 33342 staining (1 µg/ml). A P-glycoprotein inhibitor, PSC833, was co-incubated with Aβ42–488 to suppress
the transport of Aβ42–488 mediated by the P-glycoprotein. Representative images from four independent experiments are shown. n = 5 mice per experiment. Arrows
indicate the transport of Aβ42–488 into the capillary luminal space. Arrowheads indicate the reduced green fluorescence in the capillary luminal space. Scale bar,
10 µm. (B) Transport of Aβ42–488 in capillaries at 4 h after purification. The assay condition was the same as described in (A). Arrowheads indicate decreased
capillary luminal green fluorescence. (C) Endothelial markers, CD31, was used to examine the viable endothelial cells in purified capillaries at 0 h, 4 h, and 7 h after
purification. The cell nuclei are shown as blue using Hoechst 33342 staining (1 µg/ml). Scale bar, 10 µm.
various subregions of the brain (Saliba et al., 2014; Cembrowski,
2019; Kalluri et al., 2019). Yousef and colleagues recently applied
enzymatic digestion procedures following flow cytometry sorting
to characterize the molecular phenotype of brain endothelial
cells in the aging mouse brain (Czupalla et al., 2018; Yousef et al.,
2018, 2019). Since we obtained the structurally and functionally
intact brain capillaries, we further optimized the procedures to
generate single-cell suspensions with relatively shortened time
(15 vs. 50 min) and lowered dose of collagenase (0.5 mg/ml
vs. 1 mg/ml) digestion step to minimize the potential of cell
activation compared with other methods (Czupalla et al., 2018;
Yousef et al., 2018; Kalluri et al., 2019). We used 10% fetal
bovine serum to inactivate collagenase activity and stabilize cells
rapidly during collection procedures. Following the procedures
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FIGURE 7 | Fluorescence-activated cell sorting (FACS) analysis of single-cell suspensions of isolated brain microvessels. (A) Single-cell suspensions were examined
under a fluorescent microscope immediately after resuspension. The cell nuclei were stained with Hoechst 33342 (1 µg/ml). Scale bar, 50 µm. (B) Single-cell
suspensions were gated on FSC-A and SSC-A to exclude cell debris. (C) Cells were gated on FSC-W and FSC-A to exclude cell doublets or aggregates. (D) 7-AAD
uptake indicates dead cells, which account for approximately 13% of cells. (E) CD45- cells were gated to exclude monocytes/macrophages and brain resident
microglial cells. (F,G) ACSA-2 and CD31 staining were applied to examine different cell types within the single-cell suspensions generated from isolated microvessel
fragments. Representative FACS images were from three to four independent experiments.
described, we were able to generate single-cell suspensions as
examined under a fluorescence microscope (Figure 7A). The
viable cells accounted for approximately 87% of the total single
cells using 7-AAD uptake analysis (Figures 7B–D). We observed
heterogeneous cell populations with minimal contamination
of 2% CD45+ immune cell populations (Figure 7E). As we
observed astrocyte end-feet covered the wall of isolated brain
capillaries, we used astrocyte cell surface antigen-2 (ACSA-2)
and CD31 to characterize BBB component cell types within
the single-cell suspensions (Figures 7F,G). Cumulatively, this
protocol is highly reproducible. We were able to yield an average
of 4–6 × 105 cells from a pool of cerebral cortices collected from
four to five adult mice.
Potential Pitfalls and Troubleshooting
This protocol describes the relative ease in isolating
the microvessels from the adult mouse brain. Here,
we list several conditions that will facilitate the
preservation of cellular interactions between microvascular
endothelial cells and mural cells, which is critical
for maintaining the molecular phenotypes of BBB
component cells.
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• Keep all tools and buffers ice-cold to maintain a high viability
(>80%). Also, performing the majority of the steps in a 4◦C
cold room will help keeping the cells viable.
• Each isolation of cerebral microvascular fragments should
include experimental and control groups. The number of
mice to use per group depends on downstream analyses.
The protocol described above, especially the volume of Ficoll,
is good for 3–5 mice per group. For biochemical analyses,
such as RNA or protein quantifications, a pool of dissected
cortices from two youngmice (3–4-month-oldmale or female)
is the amount required. For imaging of functional assays
and single-cell analyses, a pool of dissected cortices from
four to five young mice (3–4-month-old male or female) is the
amount required.
• Tomaintain the high viability and functionality, themaximum
number of groups that can be isolated at one time is two
sets of mice (4–8 mice total). Increasing the total time for the
procedure is detrimental to the procedure.We found that once
the cells are in a single-cell suspension, the cells will begin loss
of viability after 30 min and will affect the results.
• Modified PBS and the Ficoll must be made the day before the
experiment and not any longer. Also, the sodium pyruvate and
the glucose can only be added on the day of the experiment and
must be used within the day of the experiment. Likewise, the
1% BSA solution is made right after the sodium pyruvate and
the glucose are added to the modified PBS.
• The flow rate during the glass beads section is critical for
the microvessel fragments to attach to the glass beads. If the
flow rate is too fast, the capillaries will not adhere to the
glass beads.
• The glass beads can be reused up to five times before
brain parenchyma will contaminate the beads, preventing
the capillary segments from adhering to the beads. Upon
completion of the experiment, the glass beads can be washed
by adding deionized water first followed by 95% ethanol to the
glass beads, swirling first, then dumping the excess ethanol out.
Rinse the glass beads twice with deionized water. Dry beads by
immersing them in 100% ethanol overnight. The glass beads
must be fully dry before being used again.
DISCUSSION
This protocol will be of significant interest in investigating
molecular mechanisms that lead to BBB dysfunction. It describes
in detail how to isolate brain microvessels while the isolated
fragments retain the structural and functional integrity of the
BBB. Freshly isolated microvessels can be used to characterize
barrier dysfunction or capillary permeability if a disease mouse
model is applied (Hartz et al., 2012).We validated the application
of this protocol using a mouse model exhibiting BBB damage
and cognitive impairment. Importantly, this protocol describes
procedures to generate single-cell suspensions from isolated
microvessels. The procedures require approximately 3–3.5 h
in total depending on the experiment groups of mice used.
The shorten time required from the described protocol can
significantly improve the quality of RNA obtained. Moreover,
the purified microvessel fragments were demonstrated retaining
the in vivo structure and function of transport. The highly viable
single-cell suspensions obtained from microvessels that retain
in situ structure provide a valuable resource for identifying
unique subpopulations of BBB component cells that might be
associated with disease progression using single-cell analyses,
such as RNA-sequencing (Yousef et al., 2019), DNAmethylation
(Hui et al., 2018), or ATAC-sequencing (Lalonde et al., 2019).
This protocol is optimized for the isolation of microvessel
fragments and capillaries from the cerebral cortex of the
adult mouse brain. However, it is crucial to consider that
the dissection of the brain region of interest is required. If
other brain sub-regions, such as sub-ventricular zone containing
neurogenic niche or highly vascularized hippocampus, are of
interest, the microdissection skill, fine forceps, and a dissection
microscope will be required. The procedures described during
brain harvest remove the thin slices from the dorsal surface
of the brain, which contains the subdural meninges. Since we
were unable to peel off the pia/arachnoid mater within the
brain parenchyma, the isolated microvessels do not contain
extra-parenchymal meningeal or large vessels on the surface
of the brain as demonstrated in the size characterization
of purified fragments. For the study interest of meningeal
vessels, other methods should be followed (Park et al., 2011;
Faraco et al., 2019).
CONCLUSION
Developing a protocol to isolate microvessel fragments is vital
to generate a model to study the BBB dysfunction in diseases.
Since the capillaries make up for roughly 1% of the whole brain in
humans, using crude brain homogenates will most likely generate
weak signals to study the BBB dysfunction as shown in our results
and reported literature (Bauer et al., 2008; Hartz et al., 2018a).
Here, we show that enrichment of the cerebral capillaries via
a density gradient and glass beads opens the door for future
experiments to examine and characterize the neurovascular
unit through various assays and molecular characterization, such
as single-cell analysis.
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